Boston University School of Medicine - Amyloid Treatment & Research Program is a clinical research site located in Boston, Massachusetts, United States 02118.
Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.
Boston University School of Medicine - Amyloid Treatment & Research Program has participated in 2 clinical trials.
Therapeutic areas: FAP, Familial Amyloid Polyneuropathy, TTR.
Sponsors: Ionis Pharmaceuticals, Inc..
Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Boston University School of Medicine - Amyloid Treatment & Research Program has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Boston University School of Medicine - Amyloid Treatment & Research Program has 2 clinical trials on record. Their work covers FAP, Familial Amyloid Polyneuropathy, TTR.
Boston University School of Medicine - Amyloid Treatment & Research Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.